Orphan Drugs: The Impact of EU Law
Describes EU legislation in the field of rare diseases…
Please find below some recent news of relevance for the life sciences sector as well as press releases and publications published by us.
Describes EU legislation in the field of rare diseases…
The article focuses on the question, how far the statutory health insurances’ right to information vis-à-vis pharmacies manufacturing cytostatic is reaching, in particular related to a potential right to information regarding the purchase prices of the pharmacies’ contract manufacturers…
Discussion of the judgement of the Higher Regional Court Karlsruhe (OLG Karlsruhe, 06.09.2012 – 4 U 110/12) regarding the provision of an IPad to a Healthcare Professional for free…
This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases…
Discussion of the ruling of the Higher Regional Court of Karlsruhe (OLG Karlsruhe, 08.03.2012 – 13 W 13/12) regarding the rejection of an expert for prejudice purposes…
This article outlines the main structures of the French Pricing & Reimbursement system for innovative pharmaceuticals…